These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2523551)

  • 41. Platelet markers of thromboembolic disease.
    Wohl H
    West J Med; 1981 Jul; 135(1):19-24. PubMed ID: 6167074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Platelet aggregation in whole blood with the impedance method in subjects with non-complicated essential arterial hypertension].
    Craveri A; Lanfredini M; Casati R; Citella C
    Minerva Med; 1988 Jun; 79(6):441-6. PubMed ID: 2967926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 46. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
    Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J
    Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in platelet function in patients with arterial hypertension].
    Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
    Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vascular complications of polycythemia].
    Najean Y; Dresch C; Poirier O
    Ann Med Interne (Paris); 1983; 134(5):390-4. PubMed ID: 6228177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.
    Bellon JL; Castellanos C; Acevedo L; Amiral J
    Semin Thromb Hemost; 1993; 19 Suppl 1():178-82. PubMed ID: 8362264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombin and plasmin activity and platelet activation in the development of venous thrombosis.
    Owen J; Kvam D; Nossel HL; Kaplan KL; Kernoff PB
    Blood; 1983 Mar; 61(3):476-82. PubMed ID: 6218846
    [No Abstract]   [Full Text] [Related]  

  • 52. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma beta-thromboglobulin and platelet factor 4 in renal failure.
    van Hulsteijn H; van Es A; Bertina R; Briët E
    Thromb Res; 1981 Oct 1-15; 24(1-2):175-80. PubMed ID: 6173932
    [No Abstract]   [Full Text] [Related]  

  • 54. Techniques for diagnosing prethrombotic states: a review.
    Sixma JJ
    Thromb Haemost; 1978 Oct; 40(2):252-9. PubMed ID: 83684
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulmonary hypertension associated with long-standing thrombocytosis.
    Rostagno C; Prisco D; Abbate R; Poggesi L
    Chest; 1991 May; 99(5):1303-5. PubMed ID: 1826875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients.
    Niort G; Bulgarelli A; Cassader M; Pagano G
    Atherosclerosis; 1988 Jun; 71(2-3):113-9. PubMed ID: 3401284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prethrombotic states in pediatrics].
    Fiori GM; Murgia G; Cocco A; Putzolu G; Mura R; Targhetta R; Biddau P
    Pediatr Med Chir; 1991; 13(2):139-45. PubMed ID: 1896379
    [No Abstract]   [Full Text] [Related]  

  • 58. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species.
    MacGregor I; Mclaughlin I; Drummond O
    Blood Coagul Fibrinolysis; 1995 Dec; 6(8):765. PubMed ID: 8825229
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibrinogenemia, determined immunonephelometrically, as a possible parameter in the evaluation of peripheral arteriosclerotic arteriopathy.
    Pola P; Savi L
    Atherosclerosis; 1978 Feb; 29(2):205-16. PubMed ID: 646850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fibrinogen as a risk factor in ischemic heart disease].
    Obradović S; Obradović D; Gligić B; Dincić D; Popović P; Orozović V
    Vojnosanit Pregl; 2003; 60(3):315-20. PubMed ID: 12891728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.